PHASE-II CLINICAL-STUDY OF CIS-DICHLORODIAMMINEPLATINUM (CDDP) AND VP-16-213 (VP16) IN COMBINATION FOR PATIENTS (PTS) WITH EXTENSIVE NON-SMALL CELL LUNG-CANCER (E-NSCLC)

被引：0
|
作者：
DHINGRA, HM [1 ]
VALDIVIESO, M [1 ]
UMSAWASDI, T [1 ]
SPITZER, G [1 ]
MURPHY, WK [1 ]
CHIUTEN, DF [1 ]
BOOSER, DJ [1 ]
MOUNTAIN, CF [1 ]
机构：
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,HOUSTON,TX 77030
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1981年 / 22卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：200 / 200
页数：1
相关论文
共 50 条
  • [1] CIS-DICHLORODIAMMINEPLATINUM (II) AND VP-16-213 COMBINATION CHEMOTHERAPY FOR NON-SMALL CELL LUNG-CANCER
    GOLDHIRSCH, A
    JOSS, RA
    CAVALLI, F
    SONNTAG, RW
    BRUNNER, KW
    MEDICAL AND PEDIATRIC ONCOLOGY, 1981, 9 (03): : 205 - 208
  • [2] VP-16-213 - A PHASE-II STUDY OF NON-SMALL CELL LUNG-CANCER (NSCLC)
    ITRI, LM
    GRALLA, RJ
    KELSEN, DP
    CHAPMAN, RA
    GOLBEY, RB
    KAUFMAN, RJ
    YOUNG, CW
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 199 - 199
  • [3] PHASE-II TRIAL OF VP-16-213 IN NON-SMALL-CELL LUNG-CANCER
    ITRI, LM
    GRALLA, RJ
    CHAPMAN, RA
    KELSEN, DP
    CASPER, ES
    GOLBEY, RB
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (01): : 45 - 47
  • [4] PHASE-II TRIAL OF VP16-213 IN NON-SMALL CELL LUNG-CANCER (NSCLC)
    CHAPMAN, R
    ITRI, L
    GRALLA, R
    KELSEN, D
    CASPER, E
    GOLBEY, R
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) : 205 - 207
  • [5] PHASE-II STUDY OF ORAL VP-16-213 IN SMALL-CELL LUNG-CANCER
    MATSUI, Y
    OSHIMA, S
    KADO, M
    NAKAYAMA, M
    SHIMOKATA, K
    SAKAI, S
    ITO, F
    CHIKATA, E
    HARA, K
    KANDA, T
    SHIMA, K
    TAKENAKA, S
    HOKAMA, S
    GENGA, K
    CANCER, 1987, 60 (12) : 2882 - 2885
  • [6] CIS-DICHLORODIAMMINEPLATINUM(II) AND VP-16-213 - ACTIVE INDUCTION REGIMEN FOR SMALL CELL-CARCINOMA OF THE LUNG
    SIEROCKI, JS
    HILARIS, BS
    HOPFAN, S
    MARTINI, N
    BARTON, D
    GOLBEY, RB
    WITTES, RE
    CANCER TREATMENT REPORTS, 1979, 63 (9-10): : 1593 - 1597
  • [7] CIS-PLATINUM AND VP-16-213 (ETOPOSIDE) COMBINATION CHEMOTHERAPY FOR ADVANCED NON-SMALL CELL LUNG-CANCER - A PHASE-II CLINICAL-TRIAL
    KLIPPSTEIN, T
    GRAUBNER, M
    BERDEL, WE
    MENDE, S
    GROPP, C
    DIEHL, V
    MITROU, PS
    ONKOLOGIE, 1983, 6 (06): : 306 - 311
  • [8] PHASE-II STUDY OF IDARUBICIN (ID) IN EXTENSIVE NON-SMALL CELL LUNG-CANCER (E-NSCLC) PATIENTS (PTS)
    UMSAWASDI, T
    JEFFRIES, D
    FELDER, TB
    DHINGRA, HM
    LEE, JS
    GLISSON, B
    NEWMAN, RA
    HONG, WK
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 217 - 217
  • [9] PHASE-II STUDY INDUCTION CHEMOTHERAPY IN SMALL CELL LUNG-CANCER (CISPLATINUM, CYCLOPHOSFAMIDE, VP-16-213)
    MEINESZ, AF
    POSTMUS, PE
    SLEYFER, DT
    SLUITER, HJ
    EUROPEAN JOURNAL OF RESPIRATORY DISEASES, 1982, 63 : 47 - 47
  • [10] CHEMOTHERAPY WITH CISPLATINUM (CDDP) AND VP-16-213 IN SMALL-CELL LUNG-CANCER (SCLC)
    IYER, PR
    MORAN, EM
    KANESHIRO, CA
    CHEN, JJ
    OTTENHEIMER, EJ
    CLINICAL RESEARCH, 1987, 35 (03): : A524 - A524
12345